Early Validation

Respana Therapeutics has received three STTR awards totaling >$3MM from the National Institutes of Health (NIH NIAID):

  • STTR Phase I - 1R41AI136294

  • STTR Phase I - 1R41AI162590

  • STTR Phase II - 2R42AI162590

3 Rivers Venture Fair Technology Showcase 2024 1st Prize

Seed grants from Phase 1 Ventures, Commonwealth of Pennsylvania

Runner-up, MilliporeSigma Advance Biotech Grant Award